Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2017
Dec. 31, 2016
Jun. 30, 2015
CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue $ 8,979 $ 37,833 $ 14,198 $ 9,871
Operating expenses        
Research and development (25,472) (87,388) (63,789) (24,137)
General and administrative (9,917) (31,106) (23,208) (10,375)
Total operating expenses (including purchases from related parties, net of reimbursements of $786, $2,067, $1,609 and $2,443) (35,389) (118,494) (86,997) (34,512)
Operating loss (26,410) (80,661) (72,799) (24,641)
Interest income 489 2,230 1,110 504
Other income , net 2,866 8,744 1,002 2,323
Loss before income taxes (23,055) (69,687) (70,687) (21,814)
Income taxes 55 (451) (892) (244)
Net loss (23,000) (70,138) (71,579) (22,058)
Deemed dividend on convertible preferred shares       (14,735)
Net loss attributable to shareholders used for basic $ (23,000) $ (70,138) $ (71,579) $ (36,793)
Net loss per ordinary share (Note 2)        
Basic and diluted (in dollars per share) $ (0.05) $ (0.13) $ (0.17) $ (0.17)
Weighted average shares outstanding:        
Basic and diluted (in shares) 424,711,900 527,637,086 424,713,997 214,704,593